Decibel Therapeutics, Inc. Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2023-06-30..
Quick ratio
Overview →Financial period ending 2023-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2023-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 26.58M USD | Liabilities, Current |
| Cash and equivalents | 39.80M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 0.00 USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2023-06-30 | (m) | $26.58M | $39.80M | (m) | $0.00 | (m) | (m) |
| 2023-03-31 | (m) | $23.18M | $38.06M | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $22.44M | $34.61M | (m) | $0.00 | (m) | (m) |
| 2022-09-30 | (m) | $23.37M | $36.68M | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $22.87M | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $18.11M | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $20.54M | $36.45M | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $16.50M | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $16.64M | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $15.19M | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $19.37M | $27.74M | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | $5.20M | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | $12.37M | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | $18.39M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.